Renal tubular actions of antihypertensive agents.
D000042:Absorption; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001834:Body Water / Q000378:metabolism; D002216:Captopril / Q000494:pharmacology; D005576:Colforsin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007684:Kidney Tubules / Q000187:drug effects* / Q000378:metabolism; D009318:Natriuresis / Q000187:drug effects; D010539:Permeability; D012964:Sodium / Q000037:antagonists & inhibitors / Q000378:metabolism; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D014667:Vasopressins; D005576:Colforsin; D002216:Captopril; D012964:Sodium; D000242:Cyclic AMP